95 related articles for article (PubMed ID: 29766361)
21. [Construction and validation of a dual-luciferase reporter gene system for screening and evaluating anti-liver fibrosis drugs that inhibit transcription of the gene encoding collagen I, chain a1].
Zhang W; Dai X; Yu H; Wang L; Sun S; Li J; Zhou Y
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):747-51. PubMed ID: 25496864
[TBL] [Abstract][Full Text] [Related]
22. Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.
Garcia AI; Buisson M; Damiola F; Tessereau C; Barjhoux L; Verny-Pierre C; Sornin V; Dondon MG; Eon-Marchais S; ; Caron O; Gautier-Villars M; Coupier I; Buecher B; Vennin P; Belotti M; Lortholary A; Gesta P; Dugast C; Noguès C; Fricker JP; Faivre L; Stoppa-Lyonnet D; Andrieu N; Sinilnikova OM; Mazoyer S
Eur J Hum Genet; 2016 Aug; 24(9):1324-9. PubMed ID: 26785832
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants in ABCA1 promoter affect transcription activity and plasma HDL level in pigs.
Dang XY; Chu WW; Shi HC; Yu SG; Han HY; Gu SH; Chen J
Gene; 2015 Jan; 555(2):414-20. PubMed ID: 25445391
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of the murine brca2 gene by CREB/ATF transcription factors.
Callens N; Baert JL; Monté D; Sunesen M; Van Lint C; de Launoit Y
Biochem Biophys Res Commun; 2003 Dec; 312(3):702-7. PubMed ID: 14680822
[TBL] [Abstract][Full Text] [Related]
25. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controls.
Bosviel R; Michard E; Lavediaux G; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Clin Chim Acta; 2011 Jul; 412(15-16):1472-5. PubMed ID: 21557934
[TBL] [Abstract][Full Text] [Related]
27. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons.
Acedo A; Hernández-Moro C; Curiel-García Á; Díez-Gómez B; Velasco EA
Hum Mutat; 2015 Feb; 36(2):210-21. PubMed ID: 25382762
[TBL] [Abstract][Full Text] [Related]
28. [Construction of SIRT1 promoter expression vector and its activity analysis as well as influence of AML1-ETO on transcriptional regulation of SIRT1 gene].
Wang Q; Dou LP; Li YH; Wang LL; Zhou L; Li DD; Wang LJ; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):12-8. PubMed ID: 25687038
[TBL] [Abstract][Full Text] [Related]
29. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
30. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
32. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
[TBL] [Abstract][Full Text] [Related]
33. Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancer.
Plourde M; Ferland A; Soucy P; Hamdi Y; Tranchant M; Durocher F; Sinilnikova O; Luu The V; ; Simard J
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):134-53. PubMed ID: 19460435
[TBL] [Abstract][Full Text] [Related]
34. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of the promoter region of the human DNA-repair gene Rad51.
Hasselbach L; Haase S; Fischer D; Kolberg HC; Stürzbecher HW
Eur J Gynaecol Oncol; 2005; 26(6):589-98. PubMed ID: 16398215
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements.
Di Giacomo D; Gaildrat P; Abuli A; Abdat J; Frébourg T; Tosi M; Martins A
Hum Mutat; 2013 Nov; 34(11):1547-57. PubMed ID: 23983145
[TBL] [Abstract][Full Text] [Related]
37. Promoter polymorphisms in genes involved in porcine myogenesis influence their transcriptional activity.
Bongiorni S; Tilesi F; Bicorgna S; Iacoponi F; Willems D; Gargani M; D'Andrea M; Pilla F; Valentini A
BMC Genet; 2014 Nov; 15():119. PubMed ID: 25377122
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
39. Functional Assessment of Clubfoot Associated HOXA9, TPM1, and TPM2 Variants Suggests a Potential Gene Regulation Mechanism.
Weymouth KS; Blanton SH; Powell T; Patel CV; Savill SA; Hecht JT
Clin Orthop Relat Res; 2016 Jul; 474(7):1726-35. PubMed ID: 27020427
[TBL] [Abstract][Full Text] [Related]
40. Multiple sequence variants of BRCA2 exon 7 alter splicing regulation.
Gaildrat P; Krieger S; Di Giacomo D; Abdat J; Révillion F; Caputo S; Vaur D; Jamard E; Bohers E; Ledemeney D; Peyrat JP; Houdayer C; Rouleau E; Lidereau R; Frébourg T; Hardouin A; Tosi M; Martins A
J Med Genet; 2012 Oct; 49(10):609-17. PubMed ID: 22962691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
